A Multi-Signal Based Monitoring System for CNS Hypersomnias

NCT ID: NCT05443373

Last Updated: 2022-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-04

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective and prospective cohort study. There are 600 subjects (age 9-45) will be collected.The purposes of this study are as follows:(1) The main purpose is to use Multi-Signal Based Monitoring System to link with brain image data and perform cross-comparison to find out possible pathological mechanisms of these CNS hypersomnias.(2) Use the Multi-Signal Based Monitoring System to link with brain image data and perform cross-comparison to further screen out these clinically significant biomarkers for CNS hypersomnias, and to find ideal and accurate physiological biomarkers that can monitor the course of the disease.(3) Utilize these precisely monitored biomarkers to track changes in the biomarkers and the long-term course of these CNS hypersomnias, and evaluate the treatment effect and prognosis.(4) Use computer machine learning and other algorithms to analyze and construct a variety of faster and more accurate prediction models for these CNS hypersomnias, thereby achieving the goal of preventive medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Excessive daytime sleepiness (EDS) is a common symptom in the general population. The prevalence ranges from 5% to 30%. And daytime drowsiness often brings negative effects, and even the daily function and the quality of life is impaired due to these hypersomnias. In some severe cases, many accidents can occur and endanger life. The current third edition of the International Classification of Sleep Disorders (ICSD 3) specifically classified "Central nervous system disorders of hypersomnolence" as Narcolepsy type 1 and type 2 ; idiopathic hypersomnia(IH), and Kleine-Levin syndrome (KLS). However, so far, except for Narcolepsy type 1, which has a relatively clear pathological mechanism that is related to the reduced secretion of hypocretin, other hypersomnia disorders such as Narcolepsy type 2, IH and KLS, that is no clear neurophysiological diagnosis standard, and the mechanism of these diseases is still not clear. Therefore, the diagnosis can only rely on the clinical symptoms and the clinical experience physicians. That is why the diagnosis of these diseases still has great difficulties and challenges. Therefore, in order to make the diagnosis more accurate, the investigators have to find out the "Biologic and neurophysiologic biomarkers" for these diseases. And let patients receive the correct treatment quickly.

The purposes of this study are as follows:

1. The main purpose is to use Multi-Signal Based Monitoring System to link with brain image data and perform cross-comparison to find out possible pathological mechanisms of these CNS hypersomnias.
2. Use the Multi-Signal Based Monitoring System to link with brain image data and perform cross-comparison to further screen out these clinically significant biomarkers for CNS hypersomnias, and to find ideal and accurate physiological biomarkers that can monitor the course of the disease.
3. Utilize these precisely monitored biomarkers to track changes in the biomarkers and the long-term course of these CNS hypersomnias, and evaluate the treatment effect and prognosis.
4. Use computer machine learning and other algorithms to analyze and construct a variety of faster and more accurate prediction models for these CNS hypersomnias, thereby achieving the goal of preventive medicine.

Research method:

This is a retrospective and prospective cohort study. There are 600 subjects (age 9-45) will be collected. These subjects will be divided into the five groups: (1) experimental group (narcolepsy Type 1, 300 subjects); (2) experimental group (narcolepsy Type 2, 100 subjects); and (3) experimental group (KLS, 100 subjects); and (4) experimental group (IH,50 subjects); and (5) healthy control group (age and gender matched healthy subjects,50 subjects). The investigators will collect all the clinical data for each subject, including clinical characteristics, sleep examination data, actigraphy, HLA typing, and brain imaging data.

Data analysis method:

Use multiple physiological signals to generate real-time quantitative algorithms and find physiological biomarkers related to hypersomnias. Use the aforementioned data were categorized and grouped through data analysis based on computer machine learning, neural network, and other algorithms. Then the investigators will build a predictive model based on the results and write a medical report and publish it.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypersomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group (narcolepsy Type 1)

experimental group (narcolepsy Type 1, 300 subjects)

No interventions assigned to this group

experimental group (narcolepsy Type 2)

experimental group (narcolepsy Type 2, 100 subjects)

No interventions assigned to this group

experimental group (KLS)

experimental group (KLS, 100 subjects)

No interventions assigned to this group

experimental group (IH)

experimental group (IH,50 subjects)

No interventions assigned to this group

healthy control group

healthy control group (age and gender matched healthy subjects,50 subjects)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with narcolepsy , Kleine-Levin syndrome(KLS) or Idiopathic Hypersomnia (IH) diagnosed by a physician who meet the ICSD-3 diagnostic criteria
2. Age: 9-45 years old
3. Those who agree to participate in this research and can sign the consent form.

Exclusion Criteria

1. Patients with epilepsy, head trauma and severe organic brain disease.
2. Patients with severe Obstructive Sleep Apnea (OSA) and severe Periodic Limb Movement Disorder (PLMD) who have not received treatment.
3. People with narcolepsy due to other physical and brain diseases.
4. Those who cannot cooperate with the brain imaging examination and neurocognitive function test.
5. Exclude those who have had brain surgery for brain tumor hemangioma, or those who have cerebral blood vessel metal clips.
6. Exclude current pacemakers.
7. Excluded those who had implanted artificial heart metal valve.
8. Those who underwent surgery within the last 3 months were excluded.
9. rule out claustrophobia
10. Those who are unwilling to participate in this research or are unwilling to fill in the consent form.
Minimum Eligible Age

9 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chang Gung Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Shu Huang, PhD

Role: STUDY_DIRECTOR

Principal Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chang Gung Memorial Hospital, Linkou

Taoyuan, , Taiwan

Site Status RECRUITING

Chang Gung Memorial Hospital

Taoyuan District, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu-Shu Huang, PhD

Role: CONTACT

+886 3 3281200 ext. 3836

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yu-shu Huang, MD.PhD.

Role: primary

886-975365659

Yu-Shu Huanh, PhD

Role: primary

+886 3 328200 ext. 3836

References

Explore related publications, articles, or registry entries linked to this study.

Abe K. Lithium prophylaxis of periodic hypersomnia. Br J Psychiatry. 1977 Mar;130:312-3. doi: 10.1192/bjp.130.3.312. No abstract available.

Reference Type RESULT
PMID: 843779 (View on PubMed)

Anderson KN, Pilsworth S, Sharples LD, Smith IE, Shneerson JM. Idiopathic hypersomnia: a study of 77 cases. Sleep. 2007 Oct;30(10):1274-81. doi: 10.1093/sleep/30.10.1274.

Reference Type RESULT
PMID: 17969461 (View on PubMed)

Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012 Oct;11(10):918-28. doi: 10.1016/S1474-4422(12)70187-4.

Reference Type RESULT
PMID: 22995695 (View on PubMed)

Ali M, Auger RR, Slocumb NL, Morgenthaler TI. Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med. 2009 Dec 15;5(6):562-8.

Reference Type RESULT
PMID: 20465024 (View on PubMed)

Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997 Aug;120 ( Pt 8):1423-35. doi: 10.1093/brain/120.8.1423.

Reference Type RESULT
PMID: 9278632 (View on PubMed)

Brankack J, Kukushka VI, Vyssotski AL, Draguhn A. EEG gamma frequency and sleep-wake scoring in mice: comparing two types of supervised classifiers. Brain Res. 2010 Mar 31;1322:59-71. doi: 10.1016/j.brainres.2010.01.069. Epub 2010 Feb 1.

Reference Type RESULT
PMID: 20123089 (View on PubMed)

CRITCHLEY M. Periodic hypersomnia and megaphagia in adolescent males. Brain. 1962 Dec;85:627-56. doi: 10.1093/brain/85.4.627. No abstract available.

Reference Type RESULT
PMID: 14023898 (View on PubMed)

Engstrom M, Hallbook T, Szakacs A, Karlsson T, Landtblom AM. Functional magnetic resonance imaging in narcolepsy and the kleine-levin syndrome. Front Neurol. 2014 Jun 25;5:105. doi: 10.3389/fneur.2014.00105. eCollection 2014.

Reference Type RESULT
PMID: 25009530 (View on PubMed)

Fraiwan L, Lweesy K, Khasawneh N, Wenz H, Dickhaus H. Automated sleep stage identification system based on time-frequency analysis of a single EEG channel and random forest classifier. Comput Methods Programs Biomed. 2012 Oct;108(1):10-9. doi: 10.1016/j.cmpb.2011.11.005. Epub 2011 Dec 16.

Reference Type RESULT
PMID: 22178068 (View on PubMed)

Frenette E, Kushida CA. Primary hypersomnias of central origin. Semin Neurol. 2009 Sep;29(4):354-67. doi: 10.1055/s-0029-1237114. Epub 2009 Sep 9.

Reference Type RESULT
PMID: 19742411 (View on PubMed)

Grimaldi D, Pierangeli G, Barletta G, Terlizzi R, Plazzi G, Cevoli S, Franceschini C, Montagna P, Cortelli P. Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy. Clin Neurophysiol. 2010 Jul;121(7):1142-7. doi: 10.1016/j.clinph.2010.01.028. Epub 2010 Feb 23.

Reference Type RESULT
PMID: 20181520 (View on PubMed)

Grosse-Wentrup M, Liefhold C, Gramann K, Buss M. Beamforming in noninvasive brain-computer interfaces. IEEE Trans Biomed Eng. 2009 Apr;56(4):1209-19. doi: 10.1109/TBME.2008.2009768.

Reference Type RESULT
PMID: 19423426 (View on PubMed)

Guilleminault C, Lopes MC, Hagen CC, da Rosa A. The cyclic alternating pattern demonstrates increased sleep instability and correlates with fatigue and sleepiness in adults with upper airway resistance syndrome. Sleep. 2007 May;30(5):641-7. doi: 10.1093/sleep/30.5.641.

Reference Type RESULT
PMID: 17552380 (View on PubMed)

Hadjiyannakis K, Ogilvie RD, Alloway CE, Shapiro C. FFT analysis of EEG during stage 2-to-REM transitions in narcoleptic patients and normal sleepers. Electroencephalogr Clin Neurophysiol. 1997 Nov;103(5):543-53. doi: 10.1016/s0013-4694(97)00064-3.

Reference Type RESULT
PMID: 9402885 (View on PubMed)

Jaussent I, Morin CM, Ivers H, Dauvilliers Y. Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study. Sci Rep. 2017 May 2;7(1):1372. doi: 10.1038/s41598-017-01547-0.

Reference Type RESULT
PMID: 28465612 (View on PubMed)

Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S, Shimizu T, Nishino S. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep. 2009 Feb;32(2):181-7. doi: 10.1093/sleep/32.2.181.

Reference Type RESULT
PMID: 19238805 (View on PubMed)

Pike M, Stores G. Kleine-Levin syndrome: a cause of diagnostic confusion. Arch Dis Child. 1994 Oct;71(4):355-7. doi: 10.1136/adc.71.4.355.

Reference Type RESULT
PMID: 7979534 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201902163A3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glymphatic MRI Study
NCT06452459 NOT_YET_RECRUITING